论文部分内容阅读
目的:探讨和分析米非司酮在治疗妇产科疾病中的临床治疗效果。方法:将2015年1月至2016年3月我院收治的109例妇产科类疾病的患者为研究对象,对所有妇产科疾病患者均采用米非司酮进行治疗。观察患者的临床治疗效果。结果:经治疗后,可知,在109例妇产科疾病患者中,终止妊娠疾病患者的治疗效果为90.48%;异位妊娠疾病患者的治疗效果为94.74%;子宫肌瘤疾病患者的治疗效果为85.00%;痛经疾病患者的治疗效果为92.31%;其他妇科疾病的患者治疗效果为86.11%。结论:综上所述,在治疗妇产科疾病中应用米非司酮药物,治疗效果显著,能够有效地减少不良反应的发生,提高治疗效果,对治愈妇产科患者疾病大有裨益。因此,值得临床推广应用。
Objective: To investigate and analyze the clinical effect of mifepristone in the treatment of obstetrics and gynecology diseases. Methods: From January 2015 to March 2016, 109 cases of obstetrics and gynecology diseases admitted to our hospital were studied. All patients with obstetrics and gynecology diseases were treated with mifepristone. Observe the clinical effect of the patient. Results: After treatment, we can see that in 109 cases of obstetrics and gynecology disease patients, the termination of pregnancy disease in patients with treatment effect was 90.48%; ectopic pregnancy disease in patients with treatment effect was 94.74%; treatment of uterine fibroid disease in patients with 85.00%. The treatment effect of dysmenorrhea patients was 92.31%. The treatment effect of other gynecological diseases patients was 86.11%. Conclusion: In summary, the application of mifepristone in the treatment of obstetrics and gynecology diseases, the treatment effect is significant, can effectively reduce the incidence of adverse reactions, improve the therapeutic effect of the treatment of obstetrics and gynecology patients benefit a lot. Therefore, it is worth to promote clinical application.